iX Biopharma secures $52.8m US contract for pain reliever trials

The funding will be allocated for the late-stage development of Wafermine.

Singapore-listed iX Biopharma has secured a $52.8m (US$41m) contract from the US Department of Defense to fund late-stage development of Wafermine, a fast-dissolving sublingual ketamine wafer, according to a press release.

The company said the treatment is intended for situations where conventional pain management is impractical or delayed, including battlefield trauma, emergency response, remote care, and mass-casualty settings.

The programme will support Phase 3 clinical development and a potential Emergency Use Authorisation pathway.

The announcement was followed by a placement agreement with OCBC to raise at least $6m at $0.198 per share from institutional and accredited investors. Strong demand subsequently led to an upsized placement of approximately $15m.

About $13m is earmarked for execution of the US government programme and working capital, whilst $2m is for debt repayment.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia